|
Shukra Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
1396.40 Cr.
|
P/BV
|
16.21
|
Book Value (Rs.)
|
1.97
|
|
52 Week High/Low (Rs.)
|
65/12
|
FV/ML
|
1/1
|
P/E(X)
|
145.88
|
|
Bookclosure
|
18/09/2025
|
EPS (Rs.)
|
0.22
|
Div Yield (%)
|
0.03
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 11.27 | 8.73 |
| Total Income From Operations | 11.27 | 8.73 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 9.56 | 2.37 |
| Purchase of Traded Goods | 0.00 | 0.86 |
| Increase/Decrease in Stocks | -6.78 | -0.84 |
| Employees Cost | 4.02 | 2.81 |
| Depreciation | 1.60 | 1.36 |
| Other Expenses | 3.57 | 2.05 |
| Total Expenses | 11.96 | 8.62 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.70 | 0.11 |
| Other Income | 2.82 | 1.74 |
| P/L Before Interest, Excpt. Items & Tax | 2.13 | 1.84 |
| Interest | 0.55 | 0.17 |
| P/L Before Exceptional Items & Tax | 1.57 | 1.67 |
| P/L Before Tax | 1.57 | 1.67 |
| Tax | -1.84 | 0.65 |
| P/L After Tax from Ordinary Activities | 3.41 | 1.02 |
| Net Profit/Loss For the Period | 3.41 | 1.02 |
| Net P/L After Minority Interest & Share Of Associates | 3.41 | 1.02 |
| | | |
| Equity Share Capital | 43.79 | 43.79 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.07 | 0.02 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.07 | 0.02 |
| | | |
| PBITOE Margin (%) | -6.16 | 1.25 |
| PBTE Margin (%) | 13.96 | 19.14 |
| PBT Margin (%) | 13.96 | 19.14 |
| PAT Margin (%) | 30.26 | 11.72 |
| PAT After MI And SOA Margin (%) | 30.26 | 11.72 |
